Purchase APPP
Discount program, second-order - 5% OFF, third order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy APPP for sale
α-Pyrrolidinopropiophenone (α-PPP, APPP) is a stimulant drug. It is similar in structure to the appetite-suppressant diethylpropion and has similar effects in animals. Little is known about this compound, but laboratories have detected it in Germany as an ingredient in 'ecstasy' tablets seized by law enforcement authorities. This drug has been found to produce stimulant effects in animals and presumably also produces these effects in humans, based on the context in which it has been found.
APPP is a stimulant drug. It is similar in structure to the appetite-suppressant diethylpropion and has similar effects in animals. There are few studies of this drug because it is rare. However, based on the context in which it has been found, it presumably produces stimulant effects in humans.
α-Pyrrolidinopropiophenone (α-PPP, APPP) is a stimulant drug. It is similar in structure to the appetite-suppressant diethylpropion and has similar effects in animals.
In the body, α-PPP (α-Pyrrolidinopropiophenone) is changed to p-hydroxyamphetamine, an amphetamine-related drug. The effects of p-hydroxyamphetamine in experimental studies include the release of dopamine, activation of the sympathetic nervous system, elevated blood pressure and heart rate, and increased body temperature.
It was presumably first synthesized by the biochemist Alexander Shulgin and reported in his book "PiHKAL" ("Phenethylamines I Have Known And Loved"). It has been found in tablets sold as ecstasy or molly. α-PPP is illegal in the U.K. under the blanket ban on substituted cathinones. Due to its structural similarity to illegal drugs such as methcathinone, it might be considered a controlled substance analog in some countries such as the U.S., Australia and New Zealand.
APPP is a stimulant drug. It is similar in structure to the appetite suppressant diethylpropion and has similar effects in animals. Little is known about this compound, but laboratories have detected it in Germany as an ingredient in "ecstasy" tablets seized by law enforcement authorities.
α-PPP is a stimulant drug found to produce stimulant effects in animals and presumably also produces these effects in humans. Similar to similarly dangerous drugs such as methcathinone puts this drug high on the list of controlled substances.
α-PPP, or α-Pyrrolidinopentiophenone, is a stimulant drug that acts as a norepinephrine-dopamine reuptake inhibitor and has been reported to produce p-Hydroxyamphetamine (desoxypipradrol) in vivo. This suggests that it should be treated as a controlled substance analog to methamphetamine.
Alpha-Phenyl-2-piperidinepropanolamine or 'α-PPP' is a stimulant drug often compared to other drugs with similar effects and addictive potential, such as methcathinone. It is also often found in products that promote sexual performance, like "herbal Viagra."
Alpha-PPP is a stimulant drug found to be a dopamine reuptake inhibitor in animal studies at very high doses.
There is evidence to suggest that a-PPP causes stimulant effects in animals and humans. Like other dangerous substances, such as mephedrone, it has been banned in the U.S.
This chemical is a stimulant. It can cause dizziness and difficulty with motor coordination and produces euphoria.
Appetite-suppressant and stimulant drug that has similar effects in animals to methcathinone but is less potent. Alcohol consumption would lead to the ingestion of this compound.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics